AIF1 and diabetic retinopathy: Our results are, however, in contrast with two recent studies showing that BNN27 administration can reduce Iba-1+ microglia and pro-inflammatory cytokines in the cuprizone-induced experimental multiple sclerosis (MS)29 or in the streptozotocin-induced experimental diabetic retinopathy (DR)30.